Hikma Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	402	359	190	188	421
Depreciation & Amortization	204	189	190	185	169
Other Amortization	8	8	8	8	11
Loss (Gain) From Sale of Assets	1	1	-	-6	1
Asset Writedown & Restructuring Costs	26	-29	61	179	-35
Loss (Gain) From Sale of Investments	-1	-1	-2	2	-
Loss (Gain) on Equity Investments	-	-1	-	-	1
Stock-Based Compensation	23	27	25	22	29
Other Operating Activities	24	146	56	83	69
Change in Accounts Receivable	-97	-144	-24	4	-166
Change in Inventory	-86	-112	-115	-102	38
Change in Accounts Payable	38	78	88	16	14
Change in Other Net Operating Assets	-106	43	131	-49	86
Operating Cash Flow	436	564	608	530	638
Operating Cash Flow Growth	-22.70%	-7.24%	14.72%	-16.93%	37.50%
Capital Expenditures	-197	-165	-169	-138	-145
Sale of Property, Plant & Equipment	-	10	18	1	-
Cash Acquisitions	-	-150	-98	-373	-
Divestitures	-	-	-	-1	-
Sale (Purchase) of Intangibles	-120	-70	-35	-78	-84
Investment in Securities	-3	-2	-26	-15	3
Other Investing Activities	-68	-4	-23	-3	-12
Investing Cash Flow	-388	-381	-333	-607	-238
Short-Term Debt Issued	349	387	437	380	383
Long-Term Debt Issued	2,402	684	778	1,401	10
Total Debt Issued	2,751	1,071	1,215	1,781	393
Short-Term Debt Repaid	-357	-411	-467	-363	-431
Long-Term Debt Repaid	-2,104	-557	-851	-971	-76
Total Debt Repaid	-2,461	-968	-1,318	-1,334	-507
Net Debt Issued (Repaid)	290	103	-103	447	-114
Repurchase of Common Stock	-36	-38	-	-300	-
Common Dividends Paid	-185	-175	-137	-125	-120
Other Financing Activities	-94	-78	-97	-80	-53
Financing Cash Flow	-25	-188	-337	-58	-287
Foreign Exchange Rate Adjustments	6	-12	-3	-21	-10
Net Cash Flow	29	-17	-65	-156	103
Free Cash Flow	239	399	439	392	493
Free Cash Flow Growth	-40.10%	-9.11%	11.99%	-20.49%	68.84%
Free Cash Flow Margin	7.14%	12.76%	15.27%	15.57%	19.31%
Free Cash Flow Per Share	1.07	1.78	1.97	1.74	2.12
Cash Interest Paid	83	84	82	68	50
Cash Income Tax Paid	124	125	129	55	129
Levered Free Cash Flow	-119.63	290.13	449	244.38	269.75
Unlevered Free Cash Flow	-53.38	337	494.63	281.25	296.63
Change in Working Capital	-251	-135	80	-131	-28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.